News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,927 Results
Type
Article (42465)
Company Profile (437)
Press Release (673025)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (208868)
Career Advice (2030)
Deals (36042)
Drug Delivery (104)
Drug Development (83624)
Employer Resources (173)
FDA (16459)
Job Trends (15109)
News (353091)
Policy (33173)
Tag
Academia (2646)
Accelerated approval (6)
Adcomms (24)
Allergies (87)
Alliances (50998)
ALS (97)
Alzheimer's disease (1435)
Antibody-drug conjugate (ADC) (144)
Approvals (16445)
Artificial intelligence (274)
Autoimmune disease (26)
Automation (16)
Bankruptcy (372)
Best Places to Work (11847)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (330)
Bladder cancer (83)
Brain cancer (27)
Breast cancer (294)
Cancer (2357)
Cardiovascular disease (191)
Career advice (1698)
Career pathing (30)
CAR-T (160)
Cell therapy (453)
Cervical cancer (20)
Clinical research (67873)
Collaboration (892)
Company closure (1)
Compensation (560)
Complete response letters (24)
COVID-19 (2651)
CRISPR (47)
C-suite (262)
Cystic fibrosis (106)
Data (2309)
Decentralized trials (2)
Denatured (28)
Depression (52)
Diabetes (280)
Diagnostics (6439)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (109)
Drug shortages (26)
Duchenne muscular dystrophy (102)
Earnings (88080)
Editorial (41)
Employer branding (21)
Employer resources (147)
Events (116173)
Executive appointments (755)
FDA (17801)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (798)
Gene editing (119)
Generative AI (20)
Gene therapy (336)
GLP-1 (754)
Government (4517)
Grass and pollen (4)
Guidances (108)
Healthcare (19156)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (134)
Indications (30)
Infectious disease (2799)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (99)
Interviews (312)
IPO (16817)
IRA (43)
Job creations (3705)
Job search strategy (1440)
Kidney cancer (10)
Labor market (40)
Layoffs (501)
Leadership (18)
Legal (7999)
Liver cancer (77)
Lung cancer (330)
Lymphoma (157)
Machine learning (8)
Management (58)
Manufacturing (329)
MASH (73)
Medical device (13544)
Medtech (13549)
Mergers & acquisitions (19783)
Metabolic disorders (734)
Multiple sclerosis (83)
NASH (19)
Neurodegenerative disease (105)
Neuropsychiatric disorders (33)
Neuroscience (2017)
NextGen: Class of 2025 (6760)
Non-profit (4554)
Now hiring (40)
Obesity (393)
Opinion (223)
Ovarian cancer (79)
Pain (95)
Pancreatic cancer (89)
Parkinson's disease (156)
Partnered (21)
Patents (242)
Patient recruitment (116)
Peanut (47)
People (58754)
Pharmaceutical (86)
Pharmacy benefit managers (20)
Phase I (21325)
Phase II (29954)
Phase III (22143)
Pipeline (1302)
Policy (152)
Postmarket research (2604)
Preclinical (9151)
Press Release (67)
Prostate cancer (111)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (407)
Real estate (6019)
Recruiting (66)
Regulatory (22847)
Reports (46)
Research institute (2417)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (78)
Series A (140)
Series B (93)
Service/supplier (11)
Sickle cell disease (58)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3765)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (45)
The Weekly (49)
Vaccines (716)
Venture capitalists (43)
Weight loss (257)
Women's health (37)
Worklife (17)
Date
Today (301)
Last 7 days (884)
Last 30 days (2980)
Last 365 days (33749)
2025 (11609)
2024 (36329)
2023 (41040)
2022 (52320)
2021 (56799)
2020 (54949)
2019 (47458)
2018 (35717)
2017 (33044)
2016 (32366)
2015 (38427)
2014 (32204)
2013 (27143)
2012 (29252)
2011 (29896)
2010 (28017)
Location
Africa (739)
Alabama (58)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (39332)
Australia (6541)
California (6406)
Canada (2059)
China (544)
Colorado (276)
Connecticut (289)
Delaware (156)
Europe (86078)
Florida (932)
Georgia (210)
Idaho (57)
Illinois (564)
India (25)
Indiana (317)
Iowa (12)
Japan (169)
Kansas (107)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (932)
Massachusetts (4861)
Michigan (224)
Minnesota (403)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (65)
New Hampshire (67)
New Jersey (1799)
New Mexico (30)
New York (1799)
North Carolina (1048)
North Dakota (8)
Northern California (2784)
Ohio (210)
Oklahoma (14)
Oregon (38)
Pennsylvania (1420)
Puerto Rico (12)
Rhode Island (34)
South America (1113)
South Carolina (25)
South Dakota (1)
Southern California (2392)
Tennessee (103)
Texas (952)
United States (24190)
Utah (189)
Virginia (155)
Washington D.C. (66)
Washington State (580)
West Virginia (3)
Wisconsin (57)
715,927 Results for "revision therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance
April 3, 2025
·
6 min read
Press Releases
Coloplast A/S Revised guidance for FY 2024/25
May 1, 2025
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
April 30, 2025
·
8 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025
May 7, 2025
·
5 min read
Press Releases
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
March 10, 2025
·
5 min read
Press Releases
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
April 9, 2025
·
6 min read
Press Releases
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
April 3, 2025
·
4 min read
Press Releases
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
May 2, 2025
·
3 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025
April 21, 2025
·
4 min read
1 of 71,593
Next
